Postoperative adjuvant radiotherapy for pancreatic carcinoma patients after radical resection.
- Author:
Gen-lai LIN
1
;
Zhao-chong ZENG
;
Zheng WU
;
Da-yong JIN
;
Wei-qi LU
;
Gang CHEN
;
Jian WANG
Author Information
- Publication Type:Journal Article
- MeSH: Adenocarcinoma; pathology; radiotherapy; surgery; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pancreatectomy; methods; Pancreatic Neoplasms; pathology; radiotherapy; surgery; Postoperative Period; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Survival Rate
- From: Chinese Journal of Oncology 2009;31(4):308-311
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo retrospectively investigate the difference in survival of pancreatic adenocarcinoma patients treated by radical surgery with or without adjuvant radiation therapy.
METHODSForty-four patients with pancreatic cancer underwent surgical resection with a curative intent, and were divided into two groups: surgery alone (n = 24) or surgery combined with postoperative external beam radiotherapy (EBRT) (n = 20). Survival as an endpoint was analyzed between the two groups.
RESULTSAll 44 patients completed their scheduled treatment. The median survival time of the patients treated with radical resection alone was 379 days versus 665 days for those treated with combined therapy. The 1-, 3-, 5-year survival rates of the patients treated with radical resection alone were 46.3%, 8.3%, 4.2% versus 65.2%, 20.2%, 14.1% for the patients treated with combined therapy, respectively, with a significant difference between the two groups (P = 0.017). The failures in local-regional relapse were significantly lower in the postoperative EBRT group than that in the surgery alone group (P < 0.05), while the additional postoperative radiation therapy did not increase the complication rate (P > 0.05).
CONCLUSIONPostoperative external beam radiation therapy can improve the survival in patients with pancreatic adenocarcinoma.